Edesa Biotech, Inc.

NasdaqCM EDSA

Edesa Biotech, Inc. Dividend Yield on December 05, 2024: 0.00%

Edesa Biotech, Inc. Dividend Yield is 0.00% on December 05, 2024, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Edesa Biotech, Inc. 52-week high Dividend Yield is 0.00% on December 05, 2024, which is 0.00% below the current Dividend Yield.
Edesa Biotech, Inc. 52-week low Dividend Yield is 0.00% on December 05, 2024, which is 0.00% below the current Dividend Yield.
Edesa Biotech, Inc. average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: EDSA

Edesa Biotech, Inc.

CEO	Dr. Pardeep Nijhawan FRCPC, M.D.
IPO Date	June 21, 2010
Location	Canada
Headquarters	100 Spy Court
Employees	16
Sector	Health Care
Industries Pharmaceuticals Biotechnology Clinical Trials

Description

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

Key trends

Past 5 years